Literature DB >> 9314373

Manual thromboaspiration and dilation of thrombosed dialysis access: mid-term results of a simple concept.

L Turmel-Rodrigues1, M Sapoval, J Pengloan, L Billaux, D Testou, S Hauss, A Mouton, D Blanchard.   

Abstract

PURPOSE: To report the feasibility, safety, and effectiveness of manual thromboaspiration as a single means of declotting dialysis access.
MATERIALS AND METHODS: Between April 1994 and December 1996, 59 consecutive conduits (43 polytetrafluoroethylene [PTFE] grafts, 16 native fistulas) were declotted with 8-F or 7-F angulated catheters. Unmasked stenoses were dilated. Clinical and paraclinical nephrologic surveillance (poor flow, palpation, difficulties with cannulation, increased compression times, increasing venous pressures) led to redilations and stent placements. Rethromboses were treated with further declotting by aspiration. The results are presented according to the life-table method.
RESULTS: The initial success of 43 of 43 PTFE grafts (mean procedure time, 119 min +/- 29 [standard deviation]) led to a primary patency rate of 85% +/- 5% (SE) at 1 month, 33% +/- 8% at 6 months, and 24% +/- 12% at 1 year. A graft was ligated 6 days after declotting for acute bleeding in one patient given high-dose warfarin. The secondary patency rates were 86% +/- 7% at 6 months and 86% +/- 9% at 1 year, with a mean duration of patency of 5.7 months between two radiologic interventions performed to maintain or to restore patency, and 19 stents were placed at a mean follow-up of 3 months. The success rate was 81% for native fistulas, with primary patency rates of 81% +/- 10% at 1 month, 74% +/- 14% at 6 months, and 60% +/- 27% at 1 year; secondary patency rates of 81% +/- 12% at 6 months and 81% +/- 18% at 1 year.
CONCLUSION: Thromboaspiration is a safe and effective method for declotting dialysis access, yielding a low rethrombosis rate during the first month. Overall radiologic management with reintervention on average every 6 months results in high secondary patency rates at 1 year (81%-86%).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9314373     DOI: 10.1016/s1051-0443(97)70666-3

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  9 in total

1.  Technical success rates and long-term patency of endovascular treatment for occluded native hemodialysis fistulas: comparison between thrombotic occlusion and nonthrombotic occlusion.

Authors:  Shiro Miyayama; Masashi Yamashiro; Yuichi Yoshie; Miho Okuda; Yoshiko Nakashima; Hiroshi Ikeno; Nobuaki Orito; Naokazu Ueda; Tamayo Kato; Yasuyuki Ushiogi; Osamu Matsui
Journal:  Jpn J Radiol       Date:  2010-08-27       Impact factor: 2.374

2.  Percutaneous transluminal angioplasty of a non-mainstream venous route to restore an occluded hemodialysis fistula.

Authors:  Shiro Miyayama; Masashi Yamashiro; Masaya Ikuno; Kenichiro Okumura; Miki Yoshida; Tamayo Kato; Yasuyuki Ushiogi
Journal:  Jpn J Radiol       Date:  2014-01-08       Impact factor: 2.374

3.  The primary patency of percutaneous transluminal angioplasty in hemodialysis patients with vascular access failure.

Authors:  Woo Shin Kim; Wook Bum Pyun; Byung Chul Kang
Journal:  Korean Circ J       Date:  2011-09-29       Impact factor: 3.243

4.  Declotting, maintenance, and avoiding procedural complications of native arteriovenous fistulae.

Authors:  George Zaleski
Journal:  Semin Intervent Radiol       Date:  2004-06       Impact factor: 1.513

5.  Percutaneous treatment of thrombosed arteriovenous fistulas: clinical and economic implications.

Authors:  Luís Coentrão; Pedro Bizarro; Carlos Ribeiro; Ricardo Neto; Manuel Pestana
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-26       Impact factor: 8.237

Review 6.  Hemodialysis access thrombosis.

Authors:  Keith Bertram Quencer; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

7.  Endovascular Declotting of Wall-Adherent Thrombi in Hemodialysis Vascular Access.

Authors:  Chih-Wei Hung; Chao-Lun Lai; Mu-Yang Hsieh; Ruei-Cheng Kuo; Kuei-Chin Tsai; Lin Lin; Chih-Cheng Wu
Journal:  Acta Cardiol Sin       Date:  2014-03       Impact factor: 2.672

8.  Percutaneous treatment of failed native dialysis fistulas: use of pulse-spray pharmacomechanical thrombolysis as the primary mode of therapy.

Authors:  Sung Ki Cho; Heon Han; Sam Soo Kim; Ji Yeon Lee; Sung Wook Shin; Young Soo Do; Kwang Bo Park; Sung Wook Choo; In-Wook Choo
Journal:  Korean J Radiol       Date:  2006 Jul-Sep       Impact factor: 3.500

9.  Pharmacomechanical thrombolysis for the treatment of thrombosed native arteriovenous fistula: a single-center experience.

Authors:  Ussanee Boonsrirat; Keerati Hongsakul
Journal:  Pol J Radiol       Date:  2014-10-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.